Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q3

3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥134.5bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥126.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥5.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥6.8bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥6.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.1bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥6.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥7.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥115.9bnat 2023-12-31Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥105.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥64.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥51.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥47.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥23.2bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥101.472023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.642023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥112.572022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.432022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio44.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio44.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.7bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥76m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥7.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥11.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥11.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥296m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥884m
—segment totalrevenue2023-04-01 → 2023-12-31¥134.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥134.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥373m
—segment totalsegment profit2023-04-01 → 2023-12-31¥8.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥2.6bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥115.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥115.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥66m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥11.1bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥250m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
—segment totalrevenue2022-04-01 → 2022-12-31¥126.4bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥126.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥317m
—segment totalsegment profit2022-04-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Treasury stockPrior1YearInstant-2596000000JPY
Treasury stockCurrentQuarterInstant-2350000000JPY
Shareholders equityPrior1YearInstant48823000000JPY
Shareholders equityCurrentQuarterInstant51636000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-14000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-5000000JPY
Valuation and translation adjustmentsPrior1YearInstant-14000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-5000000JPY
Non controlling interestsPrior1YearInstant47000000JPY
Non controlling interestsCurrentQuarterInstant44000000JPY
Net assetsPrior1YearInstant48856000000JPY
Net assetsCurrentQuarterInstant51675000000JPY
Liabilities and net assetsPrior1YearInstant101905000000JPY
Liabilities and net assetsCurrentQuarterInstant115922000000JPY
Net salesPrior1YTDDuration126101000000JPY
Net salesCurrentYTDDuration134528000000JPY
Cost of salesPrior1YTDDuration108961000000JPY
Cost of salesCurrentYTDDuration117559000000JPY
Gross profitPrior1YTDDuration17139000000JPY
Gross profitCurrentYTDDuration16968000000JPY
Selling general and administrative expensesPrior1YTDDuration10297000000JPY
Selling general and administrative expensesCurrentYTDDuration11238000000JPY
Operating incomePrior1YTDDuration6841000000JPY
Operating incomeCurrentYTDDuration5729000000JPY
House rent income noiPrior1YTDDuration47000000JPY
House rent income noiCurrentYTDDuration95000000JPY
Commission fee noiPrior1YTDDuration89000000JPY
Commission fee noiCurrentYTDDuration92000000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration－JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration1000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration－JPY
Equity in earnings of affiliates noiCurrentYTDDuration608000000JPY
Subsidy income noiPrior1YTDDuration8000000JPY
Subsidy income noiCurrentYTDDuration10000000JPY
Guarantee commission received noiPrior1YTDDuration44000000JPY
Guarantee commission received noiCurrentYTDDuration44000000JPY
Subsidy income noi bountyPrior1YTDDuration95000000JPY
Subsidy income noi bountyCurrentYTDDuration44000000JPY
Other noiPrior1YTDDuration121000000JPY
Other noiCurrentYTDDuration80000000JPY
Non operating incomePrior1YTDDuration407000000JPY
Non operating incomeCurrentYTDDuration977000000JPY
Interest expenses noePrior1YTDDuration59000000JPY
Interest expenses noeCurrentYTDDuration77000000JPY
Rent expenses noePrior1YTDDuration38000000JPY
Rent expenses noeCurrentYTDDuration51000000JPY
Other noePrior1YTDDuration56000000JPY
Other noeCurrentYTDDuration53000000JPY
Non operating expensesPrior1YTDDuration154000000JPY
Non operating expensesCurrentYTDDuration183000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass